
National Institute for Health and Care Research The advantages of the adaptive platform trial design
View the accessible transcript of this podcast
Professor David Sebag Montefiore talks to Professor Allan Gaw about the advantages of the adaptive platform trial design.
He zooms in on the PLATO trial (PersonaLising Anal cancer radioTherapy dose) explaining how a traditional approach would have required three separate clinical trial proposals, three separate applications, and three separate trials with three separate teams to manage them. In contrast, the platform approach enabled one research team to answer multiple research questions within one overarching trial platform.
To find out more about how the NIHR supports complex and innovative design trials, visit the NIHR website: www.nihr.ac.uk/innovative-trials
This podcast is part of our pre-pandemic series of podcasts on Complex and Innovative Design (CID) trials. You can listen to all our full collection of #ComplexInnovativeDesign trial podcasts on our website.
